Mark J. Holterman, Medical

About PAPS Membership


Pacific Association of Pediatric Surgeons pic
Pacific Association of Pediatric Surgeons

A longtime proponent of stem cell research and therapy, Mark Holterman, MD, serves as pediatrics professor at the University of Illinois College of Medicine in Peoria. Alongside his work, Dr. Mark Holterman belongs to the Pacific Association of Pediatric Surgeons (PAPS).

PAPS is an exclusive organization aimed at promoting fellowship and education among doctors who are from Pacific Rim nations. The organization currently has more than 500 members spanning 23 countries. Surgeons who spend more than 90 percent of their time in pediatric care are eligible to join the organization through geography and by invitation.

Potential applicants must either currently be practicing pediatric surgery in a Pacific-bordering country. If that surgeon moves away from the Pacific area, they can remain in the organizations by attending at least three PAPS meetings within the last decade. They must also be practicing pediatric surgeons for at least a year before becoming eligible to apply for membership.

Mark J. Holterman, Medical

American Diabetes Association Issues Joint Guidance on CGMs


American Diabetes Association pic
American Diabetes Association

Possessing decades of experience as both a physician and an educator, Mark Holterman, MD, serves as a professor of medicine at the University of Illinois College of Medicine. In addition to his work educating students, Dr. Mark Holterman is a longtime supporter of the American Diabetes Association.

Continuous glucose monitoring (CGM) systems provide people with diabetes real-time feedback about changes in their blood sugar levels. This helps them decide whether or not to eat different things or integrate some exercise into their daily routines. Even though these devices offer significant benefits to patients, they are not used as much as they could be, because a lack of standardized guidelines exist on how they should be prescribed. That’s why the American Diabetes Association has partnered with the European Association for the Study of Diabetes to issue a joint statement called “Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations.”

The new statement provides recommendations on marketing, clinical data reporting, and regulatory guidance, among other items. It can be found in the December 2017 edition of Diabetes Care and is based on a comprehensive examination of 50-plus scientific articles about CGMs.